Literature DB >> 15095475

Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L.

Silvia Bohne1, Knut Sletten, Robert Menard, Frank Bühling, Steffi Vöckler, Eike Wrenger, Albert Roessner, Christoph Röcken.   

Abstract

Cathepsin (Cath) B, CathK and CathL are cysteine proteases that participate in the lysosomal protein degradation system and are expressed in macrophages, epithelioid cells, and multinucleated histiocytic giant cells (MGCs). Both macrophages and MGCs are commonly found adjacent to immunoglobulin light chain-associated (AL) amyloid deposits, which raised the question of whether cysteine proteases are able to cleave AL amyloid proteins and AL amyloid deposits. The present study has investigated whether recombinant human CathB, CathK, and CathL are able to degrade AL(VlambdaVI) amyloid proteins and AL amyloid deposits. Using immunohistochemistry, CathB, CathK, and CathL were found adjacent to AL amyloid deposits. In vitro degradation experiments using purified AL amyloid proteins showed that CathB, CathK, and CathL degrade AL(VlambdaVI) amyloid proteins. Furthermore, using unfixed tissue sections from an amyloidotic spleen as an in vitro model for extracellular proteolysis of intact amyloid deposits, it was demonstrated that all three cysteine proteases are also capable of degrading AL amyloid in situ. This is the first study to show that cysteine proteases are able to cleave AL amyloid proteins. However, the efficiency with which proteolysis occurs depends on the concentration of active protease recruited at the sites of amyloid deposition, and possibly on the structure of the AL amyloid proteins. Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095475     DOI: 10.1002/path.1553

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  [Amyloid diagnostics in rheumatic diseases].

Authors:  C Röcken; J Ernst
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

Review 2.  [Amyloid and amyloidoses].

Authors:  C Röcken; M Eriksson
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

3.  Multiple myeloma-associated iliopsoas muscular amyloidoma first presenting with bilateral femoral nerve entrapment.

Authors:  Xinru Du; Lingxiu Zhao; Wenming Chen; Luan Jiang; Xuewei Zhang
Journal:  Int J Hematol       Date:  2012-04-07       Impact factor: 2.490

4.  Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.

Authors:  C Röcken; R Menard; F Bühling; S Vöckler; J Raynes; B Stix; S Krüger; A Roessner; T Kähne
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

5.  Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.

Authors:  Francesca Lavatelli; David H Perlman; Brian Spencer; Tatiana Prokaeva; Mark E McComb; Roger Théberge; Lawreen H Connors; Vittorio Bellotti; David C Seldin; Giampaolo Merlini; Martha Skinner; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2008-05-12       Impact factor: 5.911

6.  Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene.

Authors:  Magdalena Eriksson; Stefan Schönland; Saniye Yumlu; Ute Hegenbart; Hanna von Hutten; Zarina Gioeva; Peter Lohse; Janine Büttner; Hartmut Schmidt; Christoph Röcken
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

7.  Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutation.

Authors:  Magdalena Eriksson; Stefan Schönland; Raoul Bergner; Ute Hegenbart; Peter Lohse; Hartmut Schmidt; Christoph Röcken
Journal:  Virchows Arch       Date:  2008-05-24       Impact factor: 4.064

8.  [Amyloidosis in liver biopsies].

Authors:  Z Gioeva; B Kieninger; C Röcken
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

9.  Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations.

Authors:  Monica Gomaraschi; Laura Obici; Sara Simonelli; Gina Gregorini; Alessandro Negrinelli; Giampaolo Merlini; Guido Franceschini; Laura Calabresi
Journal:  Clin Chim Acta       Date:  2011-03-31       Impact factor: 3.786

10.  Generation and characterization of anti-AA amyloid-specific monoclonal antibodies.

Authors:  Jonathan S Wall; Stephen J Kennel; Tina Richey; Amy Allen; Alan Stuckey; Deborah T Weiss; Sallie D Macy; Robin Barbour; Peter Seubert; Alan Solomon; Dale Schenk
Journal:  Front Immunol       Date:  2011-08-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.